SEX DIFFERENCES IN DOPAMINE REUPTAKE PATHWAYS OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM IN MICE

SEX DIFFERENCES IN DOPAMINE REUPTAKE PATHWAYS OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM IN MICE

Bibliographic Details
Main Author:	Bhatt, Sandeep
Language:	English
Published:	Kent State University / OhioLINK 2006
Subjects:	Parkinson's Disease Dopamine Transporter Vesicular Monoamine Transporter 2 Neurodegeneration
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=kent1164141349

Similar Items

Big Lessons from Tiny Flies: Drosophila melanogaster as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems
by: Ameya Sanjay Kasture, et al.
Published: (2018-06-01)

Alteration to Dopaminergic Synapses Following Exposure to Perfluorooctane Sulfonate (PFOS), in Vitro and in Vivo
by: Rahul Patel, et al.
Published: (2016-08-01)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
by: Lisette Blanco-Lezcano, et al.
Published: (2018-02-01)

Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
by: Müller T
Published: (2021-03-01)

Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n–3 polyunsaturated fatty acids
by: Luc Zimmer, et al.
Published: (2000-01-01)

The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons
by: Hakeem O. Lawal, et al.
Published: (2010-10-01)

Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity
by: Seung-Mann Paek
Published: (2020-03-01)

Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway
by: Sang Soo Cho, et al.
Published: (2019-04-01)

Alterations of the Motor and Olfactory Functions Related to Parkinson’s Disease in Transgenic Mice With a VMAT2-Deficiency in Dopaminergic Neurons
by: Song Jiang, et al.
Published: (2020-04-01)

Heterogeneity of dopamine release sites in health and degeneration
by: Joseph J. Lebowitz, et al.
Published: (2020-02-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
by: Seung Ha Lee, et al.
Published: (2017-01-01)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
by: Donglang Jiang, et al.
Published: (2019-01-01)

PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES
by: Williams, Yolanda D.
Published: (2011)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
by: Silvia Paola Caminiti, et al.
Published: (2017-01-01)

Conduction states of the human dopamine transporter
by: Cameron, Krasnodara
Published: (2015)

The dopamine transporter is differentially regulated after dopaminergic lesion
by: Domingo Afonso-Oramas, et al.
Published: (2010-12-01)

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
by: Domingo Afonso-Oramas, et al.
Published: (2009-12-01)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
by: Ruihua Cao, et al.
Published: (2020-04-01)

Preliminary evidence of apathetic-like behavior in aged vesicular monoamine transporter 2 deficient mice
by: Aron Baumann, et al.
Published: (2016-11-01)

Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
by: Steven M. Graves, et al.
Published: (2021-08-01)

What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum?
by: Haruo Nishijima, et al.
Published: (2016-12-01)

Brain hypoperfusion and nigrostriatal dopaminergic dysfunction in primary familial brain calcification caused by novel MYORG variants: case report
by: Shih-Ying Chen, et al.
Published: (2020-09-01)

Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01)

Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
by: Shaili Aggarwal, et al.
Published: (2021-06-01)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
by: Diana Z. Osmanova, et al.
Published: (2019-04-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
by: Bruno P. Guiard, et al.
Published: (2011-01-01)

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
by: Noelia Granado, et al.
Published: (2011-06-01)

123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders
by: Angel Soriano Castrejón, et al.
Published: (2005-10-01)

Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01)

A novel heterocyclic compound CE-104 enhances spatial working memory in the radial arm maze in rats and modulates the dopaminergic system
by: Yogesh D Aher, et al.
Published: (2016-02-01)

Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter
by: Placido Illiano, et al.
Published: (2021-02-01)

Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease
by: Jae Jung Lee, et al.
Published: (2015-09-01)

Dopamine: A parallel pathway for modulation of locomotor networks
by: Simon eSharples, et al.
Published: (2014-06-01)

Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis
by: Burkhard Schütz
Published: (2005-10-01)

Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage
by: Rafael Franco, et al.
Published: (2021-04-01)

APRESS: Apical Regulatory Super System, Serotonin, and Dopamine Interaction [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
by: S.T. Masoud, et al.
Published: (2015-02-01)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
by: Miguel Reyes-Parada, et al.
Published: (2020-01-01)